Screener
Nurix Therapeutics, Inc. NRIX Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
| Line item | May 31,2026 | November 30,2025 |
|---|---|---|
| Stockholdersʼ equity: | ||
| Preferred stock, $0.001 par value— 10,000,000 shares authorized as of May 31, 2026 and November 30, 2025; no shares issued and outstanding as of May 31, 2026 and November 30, 2025 | — | — |
| Common stock, $0.001 par value— 500,000,000 shares authorized as of May 31, 2026 and November 30, 2025; 103,701,511 and 101,807,484 shares issued and outstanding as of May 31, 2026 and November 30, 2025, respectively | 104 | 102 |
| Additional paid-in capital | 1,582,603 | 1,541,766 |
| Accumulated other comprehensive income (loss) | (145) | 105 |
| Accumulated deficit | (1,179,935) | (1,003,226) |
| Total stockholdersʼ equity | 402,627 | 538,747 |
| Total liabilities and stockholdersʼ equity | $535,540 | $688,135 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Nurix Therapeutics, Inc.'s retained earnings?
- Nurix Therapeutics, Inc. (NRIX) reported retained earnings of -$1.18B in Q1 2026.
- How has Nurix Therapeutics, Inc.'s retained earnings changed year-over-year?
- Nurix Therapeutics, Inc.'s retained earnings decreased by 40.7% year-over-year, from -$838.58M to -$1.18B.
- What is the long-term trend for Nurix Therapeutics, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s retained earnings has grown at a 57.4% compound annual growth rate (CAGR), from -$103.7M to -$1B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Nurix Therapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude